» Articles » PMID: 32784563

Electroresponsive Silk-Based Biohybrid Composites for Electrochemically Controlled Growth Factor Delivery

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Aug 14
PMID 32784563
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Stimuli-responsive materials are very attractive candidates for on-demand drug delivery applications. Precise control over therapeutic agents in a local area is particularly enticing to regulate the biological repair process and promote tissue regeneration. Macromolecular therapeutics are difficult to embed for delivery, and achieving controlled release over long-term periods, which is required for tissue repair and regeneration, is challenging. Biohybrid composites incorporating natural biopolymers and electroconductive/active moieties are emerging as functional materials to be used as coatings, implants or scaffolds in regenerative medicine. Here, we report the development of electroresponsive biohybrid composites based on silkworm fibroin and reduced graphene oxide that are electrostatically loaded with a high-molecular-weight therapeutic (i.e., 26 kDa nerve growth factor-β (NGF-β)). NGF-β-loaded composite films were shown to control the release of the drug over a 10-day period in a pulsatile fashion upon the on/off application of an electrical stimulus. The results shown here pave the way for personalized and biologically responsive scaffolds, coatings and implantable devices to be used in neural tissue engineering applications, and could be translated to other electrically sensitive tissues as well.

Citing Articles

Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential.

Hao Z, Zhang Z, Wang Z, Wang Y, Chen J, Chen T Mil Med Res. 2024; 11(1):75.

PMID: 39639374 PMC: 11619216. DOI: 10.1186/s40779-024-00576-x.


Stimuli-responsive silk fibroin for on-demand drug delivery.

Lin X, Cai L, Cao X, Zhao Y Smart Med. 2024; 2(2):e20220019.

PMID: 39188280 PMC: 11235688. DOI: 10.1002/SMMD.20220019.


Impact of the Reduction Time-Dependent Electrical Conductivity of Graphene Nanoplatelet-Coated Aligned Silk Scaffolds on Electrically Stimulated Axonal Growth.

Das J, Upadhyay J, Monaghan M, Borah R ACS Appl Bio Mater. 2024; 7(4):2389-2401.

PMID: 38502100 PMC: 11022174. DOI: 10.1021/acsabm.4c00052.


A comprehensive review of silk-fibroin hydrogels for cell and drug delivery applications in tissue engineering and regenerative medicine.

Madappura A, Madduri S Comput Struct Biotechnol J. 2023; 21:4868-4886.

PMID: 37860231 PMC: 10583100. DOI: 10.1016/j.csbj.2023.10.012.


Magnetic-Responsive Carbon Nanotubes Composite Scaffolds for Chondrogenic Tissue Engineering.

Saranya M, da Silva A, Karjalainen H, Klinkenberg G, Schmid R, McDonagh B Adv Healthc Mater. 2023; 12(30):e2301787.

PMID: 37660271 PMC: 11468560. DOI: 10.1002/adhm.202301787.


References
1.
Ryan A, Kearney C, Shen N, Khan U, Kelly A, Probst C . Electroconductive Biohybrid Collagen/Pristine Graphene Composite Biomaterials with Enhanced Biological Activity. Adv Mater. 2018; 30(15):e1706442. DOI: 10.1002/adma.201706442. View

2.
Kasper M, Deister C, Beck F, Schmidt C . Bench-to-Bedside Lessons Learned: Commercialization of an Acellular Nerve Graft. Adv Healthc Mater. 2020; 9(16):e2000174. DOI: 10.1002/adhm.202000174. View

3.
Amdursky N, Wang X, Meredith P, Bradley D, Stevens M . Long-Range Proton Conduction across Free-Standing Serum Albumin Mats. Adv Mater. 2016; 28(14):2692-8. PMC: 4862025. DOI: 10.1002/adma.201505337. View

4.
Bengtson S, Knudsen K, Kyjovska Z, Berthing T, Skaug V, Levin M . Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide. PLoS One. 2017; 12(6):e0178355. PMC: 5453440. DOI: 10.1371/journal.pone.0178355. View

5.
Aloe L, Rocco M, Bianchi P, Manni L . Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med. 2012; 10:239. PMC: 3543237. DOI: 10.1186/1479-5876-10-239. View